Cargando…
Biomarker Testing for People With Advanced Lung Cancer in England
INTRODUCTION: Optimal management of people with advanced NSCLC depends on accurate identification of predictive markers. Yet, real-world data in this setting are limited. We describe the impact, timeliness, and outcomes of molecular testing for patients with advanced NSCLC and good performance statu...
Autores principales: | Adizie, Jana B., Tweedie, Judith, Khakwani, Aamir, Peach, Emily, Hubbard, Richard, Wood, Natasha, Gosney, John R., Harden, Susan V., Beckett, Paul, Popat, Sanjay, Navani, Neal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474239/ https://www.ncbi.nlm.nih.gov/pubmed/34590024 http://dx.doi.org/10.1016/j.jtocrr.2021.100176 |
Ejemplares similares
-
Apples and pears? A comparison of two sources of national lung cancer audit data in England
por: Khakwani, Aamir, et al.
Publicado: (2017) -
Using patient experiences to evaluate care and expectations in lung cancer: analysis of the English Cancer Patient Experience Survey linked with the national cancer registry
por: Nartey, Yvonne, et al.
Publicado: (2022) -
Small-Cell Lung Cancer in England: Trends in Survival and Chemotherapy Using the National Lung Cancer Audit
por: Khakwani, Aamir, et al.
Publicado: (2014) -
Use of systemic anti-cancer treatments in advanced stage non-small cell lung cancer during the SARS-CoV-2 pandemic in England and Wales: an analysis of the Rapid Cancer Registration Dataset
por: Morgan, Helen, et al.
Publicado: (2022) -
The impact of the Covid-19 pandemic on lung cancer incidence in England: an analysis of the 2019 and 2020 Rapid Cancer Registration Datasets
por: Gysling, Savannah, et al.
Publicado: (2022)